SET SMS ALERT
BSE - No shares traded
High
332.00
Low
326.45
Laurus Labs Ltd.
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
LIVE
BSE
Feb 21, 16:00
334.20
3.95 (+1.20%)
VOLUME 1,498
AVERAGE VOLUME
| 5-Day | 2,081 |
| 10-Day | 57,733 |
| 30-Day | 31,845 |
VOLUME SHOCKER
| 5-Day | 2,081 |
| 10-Day | 57,733 |
| 30-Day | 31,845 |
Prev. Close
330.25
Open Price
332.25
Bid PRICE (QTY.)
334.20 (45)
Offer PRICE (Qty.)
334.20 (155)
Market
Depth
Depth
Market Depth (21 Feb 2019)
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 40 | 333.10 | 334.80 | 8 |
| 10 | 333.05 | 334.90 | 51 |
| 17 | 333.00 | 335.60 | 50 |
| 10 | 332.10 | 336.80 | 6 |
| 34 | 332.05 | 339.50 | 5 |
| 433 | Total | 195 | Total |
Buy Qty
433
Sell QTY
195
Today's Low/High
330.40
339.65
52 Wk Low/High
324.00
547.50
L/U Price Band
264.20
396.30
LIVE
NSE
Feb 21, 15:42
333.50
5.05 (+1.54%)
VOLUME 10,192
AVERAGE VOLUME
| 5-Day | 17,661 |
| 10-Day | 17,915 |
| 30-Day | 31,186 |
VOLUME SHOCKER
| 5-Day | 17,661 |
| 10-Day | 17,915 |
| 30-Day | 31,186 |
Prev. Close
328.45
Open Price
332.00
Bid PRICE (QTY.)
333.50 (200)
Offer PRICE (Qty.)
0.00 (0)
- Quote
- CHARTS
- NEWS
- COMMENTS2 new
- ANNOUNCEMENTS
- CORPORATE ACTION
- FINANCIALS
- ANNUAL REPORT
- SHAREHOLDING
- PEERS
- COMPANY INFO
- ALERTS
- Widgets
- BROKER
RESEARCH
Track Laurus Labs on the go with the moneycontrol app
Action in Laurus Labs
-
-
52 Week Low
Laurus Labs has hit 52wk low of Rs 386.20 on NSE -
52 Week Low
Laurus Labs has hit 52wk low of Rs 414.40 on NSE -
52 Week Low
Laurus Labs has hit 52wk low of Rs 422.30 on BSE
Laurus Labs
Sentimeter
100%
BUY
100% of moneycontrol users recommend buying Laurus Labs.
What's your call on Laurus Labs today?
Read 2 investor views
Consolidated
MARKET CAP (Rs Cr)
3,557.12
P/E
37.17
BOOK VALUE (Rs)
139.34
DIV (%)
15.00%
Market Lot
1
INDUSTRY P/E
28.72
EPS (TTM)
8.99
P/C
16.09
PRICE/BOOK
2.40
DIV YIELD.(%)
0.45%
FACE VALUE (Rs)
10.00
DELIVERABLES (%)
* Note - Trailing EPS is displayed only when latest 4 quarter results are available.
COLLAPSE ALL
Top Trading Ideas
15 February 2019
sell TitanCompany Feb Fut |
Entry Price (Rs) 1,043.55 |
Exit Price (Rs) 1,028.00 |
Gain (Rs) 16.00 |
sell UnitedBrewerie Feb Fut |
Entry Price (Rs) 1,401.45 |
Exit Price (Rs) 1,346.00 |
Gain (Rs) 55.00 |
Historic Prices & Simple Moving Averages
Simple Moving Averages
| Days | BSE | NSE |
| 30 | 357.66 | 357.18 |
| 50 | 367.67 | 367.17 |
| 150 | 398.78 | 398.63 |
| 200 | 417.80 | 417.72 |
Click here to view the Open, High, Low, Close, Volume and Spread data for Laurus Labs
The pre-open session lasts for 15 minutes from 9 AM to 9:15 AM and is divided into three parts. In the first 8 minutes orders are placed. These orders can be cancelled or modified during this period. In the next 4 minutes price discovery will be done, and orders will be executed. The remaining 3 minutes are the buffer period to facilitate transition between pre open and continuous trading session.
News/Videos & Announcements
News
Jan 31, 2019
Laurus Labs Q3 net profit down by 49% to Rs 17.8 cr
Announcements
Feb 21, 2019
Laurus Labs - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 08, 2019
Laurus Labs - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Videos
Stock Advice & Research Reports
Stock Advice
Research Reports
Financials
Income Statement
| Standalone | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
| Net Sales | 512.78 | 574.63 | 531.10 | 546.55 |
| Other Income | 1.41 | 10.51 | 2.58 | 5.01 |
| PBDIT | 85.67 | 75.16 | 78.29 | 114.44 |
| Net Profit | 17.48 | 17.63 | 15.93 | 46.35 |
Balance Sheet
Mar'18
(In Rs Cr)
(In Rs Cr)
| Total Share Capital | 106.03 |
| Net Worth | 1,513.30 |
| Total Debt | 867.72 |
| Net Block | 1,447.69 |
| Investments | 51.74 |
| Total Assets | 2,381.02 |
Peers
Peer Comparison
| Company Name | Last Price | % Change |
52 wk High |
52 wk Low |
Market Cap |
| Sun Pharma | 429.75 | 1.79 | 678.80 | 375.40 | 103,111.42 |
| Cipla | 543.10 | 0.38 | 678.00 | 483.75 | 43,757.27 |
| Dr Reddys Labs | 2585.50 | 2.45 | 2875.00 | 1888.00 | 42,935.04 |
| Aurobindo Pharm | 730.55 | 1.11 | 830.00 | 527.05 | 42,803.48 |
| Piramal Enter | 2240.15 | 2.01 | 3302.55 | 1796.75 | 41,227.76 |
| More » | |||||
News on Peers & Sector
Share Holding Pattern & Mutual Funds Holding
Share Holding Pattern in (%)
| Dec' 18 | Jun' 18 | Dec' 17 | Sep' 17 | |
| Promoter | 33.50 | 32.06 | 30.57 | 30.56 |
| Public (FII + DII) | 66.50 | 67.94 | 69.43 | 69.44 |
| Others | 0.00 | 0.00 | 0.00 | 0.00 |
| Total | 100.00 | 100.00 | 100.00 | 100.00 |
Mutual Funds Holding
| Scheme | No. of Shares |
| SBI Magnum Midcap Fund (G) | 1,012,801 |
| SBI Magnum Tax Gain Scheme (G) | 975,999 |
| ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Regular Plan (G) | 928,821 |
| Kotak Standard Multicap Fund - Regular Plan (G) | 698,574 |
Company Information
REGISTERED OFFICE
Address
Plot No.21 & 18, Jawaharlal Nehru Pharma City,
,Parawada,
City
Vishakapatnam
State
Andhra Pradesh
Pin Code
531021
Tel. No.
0891-3061222
Fax No.
0891-3061270
Email:
Internet
REGISTRARS
Name
Karvy Fintech Pvt. Ltd.
Address
Karvy Selenium Tower B,Plot No. 31-32, Gachibowli,
City
Hyderabad - 500032
State
Telangana
Tel. No.
040-67161500, 67162222
Fax No.
040-23420814, 23001153
Email:
Internet
MANAGEMENT
Name
Designation
M Venu Gopala Roa
Non Exe.Chairman&Ind.Director
Satyanarayana Chava
Executive Director & CEO
Ravi Kumar Venkata Vantaram
Executive Director & CFO
Chandrakanth Chereddi
Executive Director
C V Lakshmana Rao
Executive Director
Message Board & Community
Right Time + Right Stock + Right Investment = HIGH PROFIT
Radico Khaitan Recommended on Sep 28th 2017
Recommended price 154.00 | Peak from reco 500.00 225.63%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
About Laurus Labs
Laurus Labs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 3,557.12 crore.
The company management includes M Venu Gopala Roa - Non Exe.Chairman&Ind.Director, Satyanarayana Chava - Executive Director & CEO, Ravi Kumar Venkata Vantaram - Executive Director & CFO, Chandrakanth Chereddi - Executive Director, C V Lakshmana Rao - Executive Director, Narendra Ostawal - Director, Aruna Rajendra Bhinge - Independent Director, Rajesh Koshy Chandy - Independent Director, Ramesh Subrahmanian - Independent Director, Ravindranath Kancherla - Independent Director.
It is listed on the BSE with a BSE Code of 540222 and the NSE with an NSE Code of LAURUSLABS.
Its Registered office is at Plot No.21 & 18, Jawaharlal Nehru Pharma City,
,Parawada, Vishakapatnam,Andhra Pradesh - 531021.
Their Registrars are Karvy Fintech Pvt. Ltd.
Quick Links for Laurus Labs
Related Searches
Laurus Labs Stock Price, Laurus Labs Stock Quote, Laurus Labs Results , Laurus Labs News ..
More »
Follow moneycontrol
Explore Moneycontrol
Mutual Funds
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Live Sensex | Public Sector Banks | Market Statistics | Plan Insurance | Global Market | Business News | Mutual Fund | Best Portfolio Manager | Bse Sensex | Nse Nifty | Commodities Price | Silver Price/Rate in India | Gold Price/Rate in India | Crude Oil | USD to INR | Bank Fixed Deposits | Company Fixed Deposits | Small Savings Schemes | Bonds |
Budget 2019 | Tax Calculator | RBI Credit Policy | News Archive | FAQs | Financial Glossary | Message Board | Moneybhai | Think India | History India | Latest News | IBNLive News | News in Hindi | Cricket News | Online Study Material | India News |Restaurants in Kochi | Online Shopping in India | Cairn India | Euro | Infosys | Inflation | Silver | Glenmark Pharmaceuticals | Snapdeal | Starbucks | Narendra Modi | Crore
| Clear Study Doubts | Education Franchisee Opportunity | Rss Feeds
Site Map | About Us | Contact Us | Advertise | Bookmark | Disclaimer | Privacy Policy | Terms & Conditions | Careers
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.
